Ethanol enhances TNF-α-inducible NFκB activation and HIV-1-LTR transcription in CD4+ Jurkat T lymphocytes

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 5, 2000, Pages 333-343

  Dong, Qing ^a   Kelkar, Sujata ^a   Xiao, Yinghua ^a   Joshi Barve, Swati ^a   McClain, Craig J ^a   Barve, Shirish S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033746439     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.110104     Document Type: Article

References (87)

1. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: Development of immunologic and clinical abnormalities. A longitudinal study
2. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis
3. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
4. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
5. Cytokine modulation of HIV expression
6. Host factors and the pathogenesis of HIV-induced disease
7. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages
8. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage
9. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone
10. Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor
11. Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease?
12. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages
13. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat
14. Genetic regulation of human immunodeficiency virus
15. The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression
16. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
17. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
18. NF-kappa B activates the HIV promoter in neurons
19. Function and activation of NF-kappa B in the immune system
20. NF-kappa B: Ten years after
21. NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system
22. Structure, regulation and function of NF-kappa B
23. The I kappa B proteins: Multifunctional regulators of Rel/NF-kappa B transcription factors
24. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: A mechanism for cytoplasmic retention
25. The NF-kappa B and I kappa B proteins: New discoveries and insights
26. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway
27. Mechanistic aspects of NF-kappa B regulation: The emerging role of phosphorylation and proteolysis
28. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
29. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation
30. Lymphoid organs function as major reservoirs for human immunodeficiency virus
31. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
32. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study
33. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms
34. Induction of HIV-1 replication in latently infected CD4(+) T cells using a combination of cytokines
35. cAMP stimulates human immunodeficiency virus (HIV 1) from latently infected cells of monocytemacrophage lineage: Synergism with TNF-alpha
36. Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line
37. Induction of human immunodeficiency virus type 1 expression in monocytic cells by Cryptococcus neoformans and Candida albicans
38. Mycobacterium tuberculosis mannose-capped lipoarabinomannan can induce NF-kappa-B-dependent activation of human immunodeficiency virus type 1 long terminal repeat in T cells
39. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements
40. Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures
41. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells
42. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: Implications in respiratory burst activity and human immunodeficiency virus-1 expression
43. Assessing alcoholism as a risk factor for acquired immunodeficiency syndrome (AIDS)
44. Sexual transmission: A major HIV risk factor in people using drugs and alcohol
45. HIV infection and risk behaviors among heterosexuals in alcohol treatment programs
46. Human studies on alcohol and susceptibility to HIV infection
47. Undetected HIV infection among patients admitted to an alcohol rehabilitation unit
48. Alcohol and other substance use in STD clinic patients: Relationships with STDs and prevalent HIV infection
49. Risk factors for sexually transmitted disease amongst men in Harare, Zimbabwe
50. Ethanol suppression of the functional state of polymorphonuclear leukocytes obtained from uninfected and simian immunodeficiency virus infected rhesus macaques
51. Alcohol consumption alters antigen-specific Th1 responses: Mechanisms of deficit and repair
52. Ethanol inhibits early events in T-lymphocyte activation
53. Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells
54. Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: Potential immunopathogenic mechanisms
55. Alcoholism and rapid progression to AIDS after seroconversion
56. Alcohol consumption alters cytokine release during murine AIDS
57. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
58. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
59. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
60. Characterization of a herpes simplex virus sequence which binds a cellular protein as a single-stranded or double-stranded DNA or RNA
61. Cataloging blood alcohol level and alcohol consumption data in field settings: Feasibility and findings
62. Cytokines in alcoholic liver disease
63. Ethanol toxicity and oxidative stress
64. Use of transfected liver cells to evaluate potential mechanisms of alcohol-induced liver injury
65. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
66. Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex?
67. Alcohol and human immunodeficiency virus infection
68. Alcohol measuring scales may influence conclusions about the role of alcohol in human immunodeficiency virus (HIV) risk and progression to acquired immunodeficiency syndrome (AIDS)
69. Effect of chronic alcohol abuse on the CNS morbidity of HIV disease
70. Alterations in brain phosphate metabolite concentrations in patients with human immuno-deficiency virus infection
71. Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites
72. Improvement of the CD4 cell count after alcohol withdrawal in HIVpositive alcoholic patients
73. Alcohol consumption alters cytokine release during murine AIDS
74. Is alcohol consumption a cofactor in the development of acquired immunodeficiency syndrome?
75. Transgenic mouse model of ethanol as a cofactor in HIV disease
76. The effect of alcohol on HIV infection in vitro
77. Selective effect of alcohol on cellular immune responses of lymphocytes from AIDS patients
78. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy
79. Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions
80. Ultraviolet irradiation and cytokines as regulators of HIV latency and expression
81. Regulation of human retroviral latency by the NF-kappa B/I kappa B family: Inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism
82. Ciprofloxacin inhibits activation of latent human immunodeficiency virus type 1 in chronically infected promonocytic U1 cells
83. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells
84. CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers
85. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes
86. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway
87. Identification and characterization of an IkappaB kinase